MPLT
NASDAQ · Biotechnology
Maplight Therapeutics Inc
$31.43
+0.78 (+2.54%)
Open$31.34
Previous Close$30.65
Day High$32.48
Day Low$30.88
52W High$33.28
52W Low$12.24
Volume—
Avg Volume401.5K
Market Cap1.23B
P/E Ratio—
EPS$-2.60
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+101.0% upside
Current
$31.43
$31.43
Target
$63.19
$63.19
$44.21
$63.19 avg
$83.67
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 110.57M | 109.60M | 110.00M |
| Net Income | -5,057,192 | -4,807,023 | -6,303,306 |
| Profit Margin | -4.6% | -4.4% | -5.7% |
| EBITDA | -7,551,548 | -8,325,034 | -7,754,101 |
| Free Cash Flow | -7,533,825 | -4,832,804 | -6,604,673 |
| Rev Growth | +23.3% | +7.4% | -2.1% |
| Debt/Equity | 0.30 | 0.38 | 0.35 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $243.73 | +3.76% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $356.32 | +1.39% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.43 | -0.58% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $484.49 | +1.96% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $625.11 | +0.27% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $291.90 | -0.73% | 64.3 | 37.13B |